Another study has confirmed that lncRNA MALAT1 was highly expressed in patients with IPF and affected the development of IPF by regulating gene expression, inflammation, and other pathways (Lai et al. 2022). This evidence concerns the gene MALAT1 and idiopathic pulmonary fibrosis.